Biofil Chemicals and Pharmaceuticals Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 142.344 million compared to INR 37.534 million a year ago. Net loss was INR 4.149 million compared to net income of INR 1.476 million a year ago. Basic loss per share was INR 0.25 compared to basic earnings per share of INR 0.09 a year ago. For the full year, total revenue was INR 365.504 million compared to INR 298.617 million a year ago. Net income was INR 12.414 million compared to INR 12.072 million a year ago. Basic earnings per share was INR 0.76 compared to INR 0.74 a year ago.